SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Lyngbakken Magnus N.)
 

Sökning: WFRF:(Lyngbakken Magnus N.) > Circulating secreto...

  • Brynildsen, JonAkershus Univ Hosp, Dept Cardiol, Div Med, Lorenskog, Norway;Univ Oslo, Ctr Heart Failure Res, Inst Clin Med, Oslo, Norway (författare)

Circulating secretoneurin concentrations in patients with moderate to severe aortic stenosis

  • Artikel/kapitelEngelska2019

Förlag, utgivningsår, omfång ...

  • PERGAMON-ELSEVIER SCIENCE LTD,2019
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-393647
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-393647URI
  • https://doi.org/10.1016/j.clinbiochem.2019.06.008DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Background: Secretoneurin (SN) concentrations provide important prognostic information in patients with myocardial dysfunction. Whether preoperative SN concentrations improve risk assessment in patients with moderate to severe aortic stenosis (AS) is unknown. Methods: We included 57 patients with moderate to severe AS referred for presurgical evaluation. All patients were examined with comprehensive echocardiography, electrocardiogram (ECG), and biochemical measurements and compared to 10 age- and sex-matched healthy subjects. Results: Median (quartile 1-3) SN concentrations were 141 (121-163) pmol/L in AS patients and 132 (106-148) pmol/L in control subjects (p = .17). Lower estimated creatinine clearance and use of diuretics, but not standard ECG or echocardiographic indices and cardiac biomarkers, were associated with increasing SN concentrations. Fifteen patients (26%) died during 3.5 years median follow-up. SN concentrations were higher in non-survivors than survivors: 156 (133-209) vs. 140 (116-155) pmol/L, p = .007. Higher SN concentrations were associated with increased risk of mortality also after adjustment for established risk indices, biomarkers, and status regarding valvular surgery: hazard ratio per lnSN 15.13 (95% CI 1.05-219.00); p = .046. Receiver operating characteristics area under the curve for SN to predict mortality was 0.74 (95% CI 0.60-0.88) compared to 0.73 (0.59-0.87) for high-sensitivity cardiac troponin T and 0.67 (0.51-0.82) for N-terminal pro-B-type natriuretic peptide. The previously identified cut-off of SN > 204 pmol/L in cardiac surgical patients predicted mortality also in this cohort. Conclusions: SN concentrations improve risk assessment in patients with moderate to severe AS by providing additional prognostic information to established risk indices such as echocardiography, ECG, and established cardiac biomarkers.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Myhre, Peder L.Akershus Univ Hosp, Dept Cardiol, Div Med, Lorenskog, Norway;Univ Oslo, Ctr Heart Failure Res, Inst Clin Med, Oslo, Norway (författare)
  • Lyngbakken, Magnus N.Akershus Univ Hosp, Dept Cardiol, Div Med, Lorenskog, Norway;Univ Oslo, Ctr Heart Failure Res, Inst Clin Med, Oslo, Norway (författare)
  • Klaeboe, Lars GunnarUniv Oslo, Ctr Heart Failure Res, Inst Clin Med, Oslo, Norway;Oslo Univ Hosp, Rikshosp, Dept Cardiol, Oslo, Norway (författare)
  • Stridsberg, MatsUppsala universitet,Biokemisk endokrinologi(Swepub:uu)matsstri (författare)
  • Christensen, GeirUniv Oslo, Ctr Heart Failure Res, Inst Clin Med, Oslo, Norway;Oslo Univ Hosp, Inst Expt Med Res, Ulleval, Norway (författare)
  • Edvardsen, ThorUniv Oslo, Ctr Heart Failure Res, Inst Clin Med, Oslo, Norway;Oslo Univ Hosp, Rikshosp, Dept Cardiol, Oslo, Norway (författare)
  • Omland, TorbjornAkershus Univ Hosp, Dept Cardiol, Div Med, Lorenskog, Norway;Univ Oslo, Ctr Heart Failure Res, Inst Clin Med, Oslo, Norway (författare)
  • Rosjo, HelgeUniv Oslo, Ctr Heart Failure Res, Inst Clin Med, Oslo, Norway;Akershus Univ Hosp, Div Res & Innovat, Sykehusveien 25, N-1478 Lorenskog, Norway (författare)
  • Akershus Univ Hosp, Dept Cardiol, Div Med, Lorenskog, Norway;Univ Oslo, Ctr Heart Failure Res, Inst Clin Med, Oslo, NorwayUniv Oslo, Ctr Heart Failure Res, Inst Clin Med, Oslo, Norway;Oslo Univ Hosp, Rikshosp, Dept Cardiol, Oslo, Norway (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Clinical Biochemistry: PERGAMON-ELSEVIER SCIENCE LTD71, s. 17-230009-91201873-2933

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy